Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that has been associated with aberrant microbiota. This review focuses on the recent molecular insights generated by analysing the intestinal microbiota in subjects suffering from IBS. Special emphasis is given to studies that compare and contrast the microbiota of healthy subjects with that of IBS patients classified into different subgroups based on their predominant bowel pattern as defined by the Rome criteria. The current data available from a limited number of patients do not reveal pronounced and reproducible IBS-related deviations of entire phylogenetic or functional microbial groups, but rather support the concept that IBS patients have alterations in the proportions of commensals with interrelated changes in the metabolic output and overall microbial ecology. The lack of apparent similarities in the taxonomy of microbiota in IBS patients may partially arise from the fact that the applied molecular methods, the nature and location of IBS subjects, and the statistical power of the studies have varied considerably. Most recent advances, especially the finding that several uncharacterized phylotypes show non-random segregation between healthy and IBS subjects, indicate the possibility of discovering bacteria specific for IBS. Moreover, tools are being developed for the functional analysis of the relationship between the intestinal microbiota and IBS. These approaches may be instrumental in the evaluation of the ecological dysbiosis hypothesis in the gut ecosystem. Finally, we discuss the future outlook for research avenues and candidate microbial biomarkers that may eventually be used in IBS diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 6×
“Recent metagenomic sequence analysis of the GI tract microbiota has confirmed this and defined a reference set of over three million unique genes that vastly exceeds the coding capacity of the human genome (Qin et al., 2010).”
BackgroundInfluentialA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 2×
“Comparative microbiota analyses between multiple healthy subjects indicate that a limited proportion of phylotypes are shared between individuals, forming a common core microbiota that is assumed to be functionally redundant (Qin et al., 2010; Tap et al., 2009; Turnbaugh et al., 2009).”
BackgroundWoese, C. R. (1987) · Microbiological Reviews · doi:10.1128/mr.51.2.221-271.1987 · Cited by 5,042 · cited 1×
“As the evolutionary distance of different bacterial phyla is comparable with that of animals and plants in the rRNA-based tree of life (Woese, 1987), the vast genetic and phenotypic heterogeneity of the taxa classified into a phylum makes the phylum-wide differences unlikely.”
BackgroundLongstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“Interestingly, these taxa also stood out from clone libraries derived from IBD patients (Frank et al., 2007), and from an individual suffering from Clostridium difficile-associated disease (CDAD) with severe diarrhoea and colitis (Khoruts et al.”
BackgroundFunctional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Human gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880 · cited 1×
“Recently, the increase of Erysipelotrichi has been associated with obesity (Zhang et al., 2009) as well as high fat intake (Fleissner et al.”
BackgroundLow counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275 · cited 1×
“In the case of inflammatory bowel diseases (IBDs), such an approach has uncovered significant differences in overall diversity as well as in specific bacteria (Qin et al., 2010; Sokol et al., 2009).”
BackgroundAre dental diseases examples of ecological catastrophes?
Marsh, P. D. (2003) · Microbiology · doi:10.1099/mic.0.26082-0 · Cited by 1,256 · cited 1×
“This synopsis strongly suggests homeostasis of the microbiota to be a critical element in the pathophysiology of IBS, in a manner analogous to the development of dental caries according to the proposed ecological plaque hypothesis (Marsh, 2003).”
BackgroundPostinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Cited by
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462
“Other studies [62,65] confirmed and revealed some phyla and genera variations in IBS patients compared to healthy controls: an increase in the Firmicutes-to Bacteroidetes-ratio, a decrease in some Firmicutes families (Lactobacilli, Faecalibacterium) and the Actinobacteria population (Bifidobacteria, Collinsella), and…”
ResultDysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710
“In IBS, changes in microbiota composition have been described in the different subtypes of disease compared to healthy individuals (38, 39) although the changes are not uniform (40).”
BackgroundThe interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611
Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M. M., & Simrén, M. (2012) · Gut · doi:10.1136/gutjnl-2011-301501 · Cited by 835
Intestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724
“While it was previously assumed that these methanogens were only present in a minor fraction of healthy subjects, application of new DNA isolation methods has led to the observation that they are in fact highly prevalent (Dridi et al. 2009; Salonen et al. 2010b).”
BackgroundResultGastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
Saulnier, D. M., Riehle, K., Mistretta, T., Diaz, M., Mandal, D., Raza, S., Weidler, E. M., Qin, X., Coarfa, C., Milosavljevic, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.072 · Cited by 672
Tap, J., Derrien, M., Törnblom, H., Brazeilles, R., Cools-Portier, S., Doré, J., Störsrud, S., Le Nevé, B., Öhman, L., & Simrén, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.049 · Cited by 642
Luczynski, P., McVey Neufeld, K.-A., Oriach, C. S., Clarke, G., Dinan, T. G., & Cryan, J. F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw020 · Cited by 632
“Given the high comorbidity of GI and mood disorders, it makes sense that drugs targeting the serotonergic system effectively treat the symptoms of IBS and anxiety and depressive disorders (O’Mahony et al., 2015).”
BackgroundInfluentialMicrobiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 508
De Palma, G., Lynch, M. D. J., Lu, J., Dang, V. T., Deng, Y., Jury, J., Umeh, G., Miranda, P. M., Pigrau Pastor, M., Sidani, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6397 · Cited by 505
“Both IL-1a and CXCR4 have been shown to be up-regulated in both mice and patients with colitis (40, 41), with CXCR4 modulating intestinal barrier function (42) together with MKNK1, Ptk2, RAPGEF2, ATF-2, andMylk3.”
BackgroundMethodSex, body mass index, and dietary fiber intake influence the human gut microbiome
Dominianni, C., Sinha, R., Goedert, J. J., Pei, Z., Yang, L., Hayes, R. B., & Ahn, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124599 · Cited by 468
Probiotics, gut microbiota and health
Butel, M.-J. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.10.002 · Cited by 457
Role of the intestinal microbiome in health and disease: from correlation to causation
de Vos, W. M., & de Vos, E. A. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00505.x · Cited by 440
Kumar Singh, A., Cabral, C., Kumar, R., Ganguly, R., Kumar Rana, H., Gupta, A., Rosaria Lauro, M., Carbone, C., Reis, F., & Pandey, A. K. (2019) · Nutrients · doi:10.3390/nu11092216 · Cited by 433
The microbiome: stress, health and disease
Moloney, R. D., Desbonnet, L., Clarke, G., Dinan, T. G., & Cryan, J. F. (2014) · Mammalian Genome · doi:10.1007/s00335-013-9488-5 · Cited by 430
“patients may have an altered microbiota composition relative to healthy individuals, mainly based on the analysis of faecal microbiota (Salonen et al. 2010; Tana et al. 2010).”
BackgroundMohr, A. E., Jäger, R., Carpenter, K. C., Kerksick, C. M., Purpura, M., Townsend, J. R., West, N. P., Black, K., Gleeson, M., Pyne, D. B., et al. (2020) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00353-w · Cited by 378
Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome
Chassard, C., Dapoigny, M., Scott, K. P., Crouzet, L., Del'homme, C., Marquet, P., Martin, J. C., Pickering, G., Ardid, D., Eschalier, A., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05007.x · Cited by 363
Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?
Rajilić-Stojanović, M., Jonkers, D. M., Salonen, A., Hanevik, K., Raes, J., Jalanka, J., de Vos, W. M., Manichanh, C., Golic, N., Enck, P., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.427 · Cited by 359
Self-citationShang, Q., Shan, X., Cai, C., Hao, J., Li, G., & Yu, G. (2016) · Food & Function · doi:10.1039/c6fo00309e · Cited by 355
A role for the gut microbiota in IBS
Collins, S. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.40 · Cited by 351
Jalanka-Tuovinen, J., Salonen, A., Nikkilä, J., Immonen, O., Kekkonen, R., Lahti, L., Palva, A., & de Vos, W. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023035 · Cited by 340
“Several studies have reported decreased levels of Bifidobacteria in IBS patients (reviewed in [41]) and a probiotic B.”
BackgroundSelf-citationJalanka-Tuovinen, J., Salojärvi, J., Salonen, A., Immonen, O., Garsed, K., Kelly, F. M., Zaitoun, A., Palva, A., Spiller, R. C., & de Vos, W. M. (2014) · Gut · doi:10.1136/gutjnl-2013-305994 · Cited by 340
Self-citationThe human gut microbiome: current knowledge, challenges, and future directions
Dave, M., Higgins, P. D., Middha, S., & Rioux, K. P. (2012) · Translational Research · doi:10.1016/j.trsl.2012.05.003 · Cited by 336
The Impact of Microbiota on Brain and Behavior: Mechanisms & Therapeutic Potential
Borre, Y. E., Moloney, R. D., Clarke, G., Dinan, T. G., & Cryan, J. F. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_17 · Cited by 329
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
Distrutti, E., Monaldi, L., Ricci, P., & Fiorucci, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2219 · Cited by 320
Bangsgaard Bendtsen, K. M., Krych, L., Sørensen, D. B., Pang, W., Nielsen, D. S., Josefsen, K., Hansen, L. H., Sørensen, S. J., & Hansen, A. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046231 · Cited by 299
“IBS seems to be associated with the composition of the microbiome [32], and in humans, early-life stress as well as stress episodes in adult life are known as important risk factors in the development of IBS [33].”
BackgroundThe intestinal microbiota and chronic disorders of the gut
DuPont, A. W., & DuPont, H. L. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.133 · Cited by 307
“Limited study of the microbiota in patients with IBS suggests that they have alterations in the proportions of commensal bacteria, but more research is needed on this topic”
BackgroundPeripheral mechanisms in irritable bowel syndrome
Camilleri, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1207068 · Cited by 300
Microbiota regulation of the mammalian gut-brain axis
Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300
Contributions of the microbial hydrogen economy to colonic homeostasis
Carbonero, F., Benefiel, A. C., & Gaskins, H. R. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.85 · Cited by 293
Casén, C., Vebø, H. C., Sekelja, M., Hegge, F. T., Karlsson, M. K., Ciemniejewska, E., Dzankovic, S., Frøyland, C., Nestestog, R., Engstrand, L., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13236 · Cited by 289
“11 The use of these methods has signi fi - cantly increased our understanding of the role of gut microbiota in health and disease 10 ; for example, small intestinal bacterial overgrowth 12 and altered intestinal microbiota 13 are implicated in subgroups of patients with functional bowel disorders.”
Crouzet, L., Gaultier, E., Del'Homme, C., Cartier, C., Delmas, E., Dapoigny, M., Fioramonti, J., & Bernalier‐Donadille, A. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12103 · Cited by 280
Peripheral Mechanisms in Irritable Bowel Syndrome
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1214185 · Cited by 280
Imperial, I. C. V. J., & Ibana, J. A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01983 · Cited by 276
“…syndrome, Crohn’s disease, and necrotizing enterocolitis, are presently being associated with dysbiosis in the human gut microbiota (Peterson et al., 2008; Emami et al., 2009; Serino et al., 2009; Salonen et al., 2010; Angelakis et al., 2012; Snedeker and Hay, 2012; Jeffery and O’Toole, 2013).”
BackgroundMicrobial community and metabolomic comparison of irritable bowel syndrome faeces
Ponnusamy, K., Choi, J. N., Kim, J., Lee, S.-Y., & Lee, C. H. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.028126-0 · Cited by 247
“Lactobacilli produce pyroglutamic acid, bacteriocin, lactic acid and acetic acid, which act as antimicrobials and also lower the pH levels, thus preventing the colonization by other bacterial communities (Engberg et al. , 2000; Salonen et al. , 2010).”
Gut microbiota, host health, and polysaccharides
Xu, X., Xu, P., Ma, C., Tang, J., & Zhang, X. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.12.009 · Cited by 245
“Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that is associatedwith aberrant intestinalmicrobiota and shows distinct differences between healthy and IBS subjects (Salonen et al., 2010).”
The relationship between phenolic compounds from diet and microbiota: impact on human health
Valdés, L., Cuervo, A., Salazar, N., Ruas-Madiedo, P., Gueimonde, M., & González, S. (2015) · Food & Function · doi:10.1039/c5fo00322a · Cited by 235
Irritable Bowel Syndrome, Gut Microbiota and Probiotics
Lee, B. J., & Bak, Y.-T. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.3.252 · Cited by 228
Damman, C. J., Miller, S. I., Surawicz, C. M., & Zisman, T. L. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.93 · Cited by 226
“In a disturbed, or “dysbiotic,” state it is believed to play a role in many diseases, including asthma and atopic diseases (23,24), obesity and metabolic syndrome (25,26), colorectal cancer (27,28), enteric infections (29), irritable bowel syndrome (30), and inflammatory bowel disease (31–33).”
BackgroundIntestinal microbiota in early life and its implications on childhood health
Zhuang, L., Chen, H., Zhang, S., Zhuang, J., Li, Q., & Feng, Z. (2019) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.10.002 · Cited by 219
Alterations of the Gut Microbiota in Hashimoto's Thyroiditis Patients
Zhao, F., Feng, J., Li, J., Zhao, L., Liu, Y., Chen, H., Jin, Y., Zhu, B., & Wei, Y. (2018) · Thyroid · doi:10.1089/thy.2017.0395 · Cited by 215
“Several recent comprehensive studies of the microbiota in IBS patients have reported increases in the relative abundance levels of Firmicutes, mainly Clostridium cluster XIVa (Blautia, Dorea, Eubacterium_rectale_group and Ruminococcaceae), Ruminococcus_torques_group, Streptococcus and Lachnospiraceae, and their abunda…”
Rigsbee, L., Agans, R., Shankar, V., Kenche, H., Khamis, H. J., Michail, S., & Paliy, O. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.287 · Cited by 207
Wacklin, P., Kaukinen, K., Tuovinen, E., Collin, P., Lindfors, K., Partanen, J., Mäki, M., & Mättö, J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828029a9 · Cited by 207
Diet-microbiota interactions and their implications for healthy living
Jeffery, I., & O'Toole, P. (2013) · Nutrients · doi:10.3390/nu5010234 · Cited by 199
“microbiotas has been confirmed by several studies using high throughput technologies to determine the alterations of the microbiota of the distal bowel in IBS compared to healthy subjects [63,71–73].”
ResultClinical significance of lymph node metastasis in gastric cancer
Deng, J.-Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3967 · Cited by 194
Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome
Kennedy, P. J., Clarke, G., Quigley, E. M. M., Groeger, J. A., Dinan, T. G., & Cryan, J. F. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.07.001 · Cited by 193
Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms
Beatty, J. K., Akierman, S. V., Motta, J.-P., Muise, S., Workentine, M. L., Harrison, J. J., Bhargava, A., Beck, P. L., Rioux, K. P., McKnight, G. W., et al. (2017) · International Journal for Parasitology · doi:10.1016/j.ijpara.2016.11.010 · Cited by 157
Lenhart, A., & Chey, W. D. (2017) · Advances in Nutrition · doi:10.3945/an.117.015560 · Cited by 160
A clinician's guide to microbiome analysis
Claesson, M. J., Clooney, A. G., & O'Toole, P. W. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.97 · Cited by 153
Shukla, R., Ghoshal, U., Dhole, T. N., & Ghoshal, U. C. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3607-y · Cited by 166
“Altered fermentation of diets leads to the production of excess hydrogen, methane gases, and organic acids, suggesting an association of varied range of symptoms with different subgroups of IBS [36, 42].”
BackgroundMethodInfluentialThe Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?
Ghoshal, U. C., Shukla, R., Ghoshal, U., Gwee, K.-A., Ng, S. C., & Quigley, E. M. M. (2012) · International Journal of Inflammation · doi:10.1155/2012/151085 · Cited by 144
“Several studies using different methodologies to define changes in the microbiota have been published, including classic culture-based techniques, PCR-based molecular technologies such as real-time PCR (q PCR), microarray, DGGE (denaturation gradient gel electrophoresis), GC profiling, and high-throughput sequencing b…”
BackgroundCrohn’s disease and the mycobacterioses: A quarter century later. Causation or simple association?
Chiodini, R. J., Chamberlin, W., Sarosiek, J., & McCallum, R. W. (2012) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.638273 · Cited by 173
“Dysbiosis of the gastrointestinal microbiome has been described in obesity (Cani & Delzenne, 2009), coeliac disease (De Palma et al., 2010), irritable bowel syndrome (Cremon et al., 2010, Salonen et al., 2010) and colorectal cancer (Pagnini et al., 2011, Sobhani et al., 2011).”
BackgroundThe Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin
Ponziani, F. R., Scaldaferri, F., Petito, V., Sterbini, F. P., Pecere, S., Lopetuso, L. R., Palladini, A., Gerardi, V., Masucci, L., Pompili, M., et al. (2016) · Digestive Diseases · doi:10.1159/000443361 · Cited by 148
Influence of food matrices on probiotic viability – A review focusing on the fruity bases
Santo, A. P. D. E., Perego, P., Converti, A., & de Oliveira, M. N. (2011) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2011.04.008 · Cited by 153
Antibiotic-treated versus germ-free rodents for microbiota transplantation studies
Lundberg, R., Toft, M. F., August, B., Hansen, A. K., & Hansen, C. H. F. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1127463 · Cited by 134
The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors
Minalyan, A., Gabrielyan, L., Scott, D., Jacobs, J., & Pisegna, J. R. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0577-6 · Cited by 127
Altomare, A., Rosa, C. D., Imperia, E., Emerenziani, S., Cicala, M., & Guarino, M. P. L. (2021) · Nutrients · doi:10.3390/nu13051506 · Cited by 157
“In fact, colonization by Clostridium determines an excessive gas production, which is associated with IBS [73].”
BackgroundBacterial proteases in IBD and IBS
Steck, N., Mueller, K., Schemann, M., & Haller, D. (2012) · Gut · doi:10.1136/gutjnl-2011-300775 · Cited by 123
Whelan, K. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834b8082 · Cited by 120
Su, T., Liu, R., Lee, A., Long, Y., Du, L., Lai, S., Chen, X., Wang, L., Si, J., Owyang, C., et al. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/6961783 · Cited by 117
Impact of early gut microbiota on immune and metabolic development and function
Wang, M., Monaco, M. H., & Donovan, S. M. (2016) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2016.04.004 · Cited by 138
“The microbiota of IBS patients is less diverse than in healthy individuals; however, identification of bacterial signature for IBS is complicated by the presence of IBS subtypes: diarrhea-predominant IBS (IBS-D), constipation predominant (IBS-C), and mixed subtype with alternating episodes of diarrhea and constipation…”
BackgroundIntestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115
“Although early studies were relatively small with noticeable methodological limitations, their overall findings suggested differences in the intestinal microbiota of patients with IBS and healthy controls (145, 153).”
ResultIncreased Urinary Indoxyl Sulfate (Indican): New Insights into Gut Dysbiosis in Parkinson’s Disease
Cassani, E., Barichella, M., Cancello, R., Cavanna, F., Iorio, L., Cereda, E., Bolliri, C., Zampella Maria, P., Bianchi, F., Cestaro, B., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.004 · Cited by 108
“) [29].”
The microbiota link to irritable bowel syndrome: An emerging story
Jeffery, I. B., Quigley, E. M. M., Öhman, L., Simrén, M., & O'Toole, P. W. (2012) · Gut Microbes · doi:10.4161/gmic.21772 · Cited by 110
“Moreover, increased abundance of flagellin-producing species belonging to Clostridium cluster XIVa have been demonstrated in IBS by us and others.(8,10) Immune responses to bacterial flagellin are mediated through toll like receptor 5 (TLR5), which is a cellassociated pattern-recognition molecule regulating innate imm…”
BackgroundResultDurbán, A., Abellán, J. J., Jiménez‐Hernández, N., Salgado, P., Ponce, M., Ponce, J., Garrigues, V., Latorre, A., & Moya, A. (2012) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2012.00327.x · Cited by 110
“These results are in agreement with recent research on IBS that points to subtle rather than pronounced compositional deviations in the gut microbiota of IBS patients (Salonen et al., 2010).”
Beatty, J. K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3976 · Cited by 108
Carco, C., Young, W., Gearry, R. B., Talley, N. J., McNabb, W. C., & Roy, N. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00468 · Cited by 99
The Effect of Short-Term Consumption of Lactic Acid Bacteria on the Gut Microbiota in Obese People
Burakova, I. Y., Dmitrievna, S. Y., Vladimirovna, G. M., Syromyatnikov, M., Chizhkov, P. A., Попов, Е. С., & Popov, V. N. (2022) · Nutrients · doi:10.3390/nu14163384 · Cited by 101
“It is also known that there is an inverse correlation of the number of this phylum with indicators characteristic of irritable bowel syndrome [25,26].”
BackgroundThe Gut’s Little Brain in Control of Intestinal Immunity
de Jonge, W. J. (2013) · ISRN Gastroenterology · doi:10.1155/2013/630159 · Cited by 94
Stress-Related Alterations of Visceral Sensation: Animal Models for Irritable Bowel Syndrome Study
Larauche, M., Mulak, A., & Taché, Y. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.3.213 · Cited by 93
“(rifaximin or neomycin) are an effective treatment option in non-constipated IBS patients, over a 3-month period(174,175) or even longer,(176) thereby confirming the role of dysbiosis in developing IBS symptoms.(177) Surgery and somato-visceral convergence.”
BackgroundNutritional and Health Potential of Probiotics: A Review
Ranjha, M. M. A. N., Shafique, B., Batool, M., Kowalczewski, P. Ł., Shehzad, Q., Usman, M. A., Manzoor, M. F., Zahra, S. M., Yaqub, S., & Aadil, R. M. (2021) · Applied Sciences · doi:10.3390/app112311204 · Cited by 114
Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome
Hollister, E. B., Oezguen, N., Chumpitazi, B. P., Luna, R. A., Weidler, E. M., Rubio-Gonzales, M., Dahdouli, M., Cope, J. L., Mistretta, T.-A., Raza, S., et al. (2019) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.01.006 · Cited by 89
“Various unclassified Lachnospiraceae have been described in associationwith IBS on the basis of 16S rRNA gene survey data.(7,13) Lachnospiraceaeproduced flagellins can stimulate immune responses in some IBS patients,(47) and unclassified Lachnospiraceae operational taxonomic units were identified as indicator species…”
BackgroundRoberts, L. M., McCahon, D., Holder, R., Wilson, S., & Hobbs, F. R. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-45 · Cited by 88
Xiao, H., Zhong, L. L. D., Tsang, S. W., Lin, Z.-S., & Bian, Z. (2015) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x15500019 · Cited by 91
“When compared to the health subjects, populations of Lactobacilli were significantly decreased in D-IBS patients, whereas strains of Veillonella spp. were significantly increased in C-IBS patients (Salonen et al., 2010).”
ResultDlugosz, A., Winckler, B., Lundin, E., Zakikhany, K., Sandström, G., Ye, W., Engstrand, L., & Lindberg, G. (2015) · Scientific Reports · doi:10.1038/srep08508 · Cited by 83
Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome
Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Artacho, A., Garrigues, V., Ortiz, V., Ponce, J., Latorre, A., & Moya, A. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12184 · Cited by 83
“The inclusion of single samples from patients that were fairly asymptomatic at the time of sampling might partly explain the failure of most of the previous studies to discriminate IBS cases from controls on the basis of the global distribution of gut bacteria (Salonen et al., 2010; Durb an et al., 2012; Simr en et al…”
BackgroundResultInfluentialContribution of the Intestinal Microbiota to Human Health: From Birth to 100 Years of Age
Cheng, J., Palva, A., de Vos, W. M., & Satokari, R. M. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_189 · Cited by 109
“In addition, genera Streptococcus, Lactobacillus, Veillonella, Bifidobacterium, Clostridium and families Lachnospiraceae and Ruminococcaceae have been identified for accounting for the differences (Salonen et al. 2010).”
BackgroundSelf-citationArtificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome
Karakan, T., Gundogdu, A., Alagözlü, H., Ekmen, N., Ozgul, S., Tunali, V., Hora, M., Beyazgul, D., & Nalbantoglu, O. U. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2138672 · Cited by 79
“The alteration of gut microbiota composition in the IBS context has been repeatedly reported by observational studies.(4) Some investigators reported increased fecal Streptococcus(5) and Proteobacteria levels in the gut mucosa.”
BackgroundMortaş, H., Bilici, S., & Karakan, T. (2020) · Chronobiology International · doi:10.1080/07420528.2020.1778717 · Cited by 78
Development of the Zebrafish Enteric Nervous System
Shepherd, I. T., & Eisen, J. S. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-387036-0.00006-2 · Cited by 88
“These diseases may result from dysregulation of the intestinal microbiota (Baker et al., 2009; Cheesman and Guillemin, 2007; Furness, 2006; Salonen et al., 2010); thus, it is crucial to understand how the microbiota influence ENS function, and whether they also play a role in the later aspects of…”
Chen, Q., Ren, Y., Lu, J., Bartlett, M., Chen, L., Zhang, Y., Guo, X., & Liu, C. (2017) · Nutrients · doi:10.3390/nu9121341 · Cited by 84
The potential for probiotic manipulation of the gastrointestinal microbiome
Rauch, M., & Lynch, S. V. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.11.004 · Cited by 90
Unraveling the ties between irritable bowel syndrome and intestinal microbiota
Hong, S. N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2470 · Cited by 75
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Khalil, M., Ciaula, A. D., Mahdi, L., Jaber, N., Palo, D. M. D., Graziani, A., Baffy, G., & Portincasa, P. (2024) · Microorganisms · doi:10.3390/microorganisms12112333 · Cited by 114
“Nevertheless, the above-mentioned findings point to the disruption of healthy microbiota and change in epithelial barrier function in IBS patients [412,413].”
Effects of dietary fibre source on microbiota composition in the large intestine of suckling piglets
Zhang, L., Mu, C., He, X., Su, Y., Mao, S., Zhang, J., Smidt, H., & Zhu, W. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw138 · Cited by 81
Bonfrate, L., Tack, J., Grattagliano, I., Cuomo, R., & Portincasa, P. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.799220 · Cited by 67
“Further investigations are required to link bacterial genes with GI symptoms, for example by identifying key bacterial enzymes relevant to the IBS process [101].”
BackgroundThe microbiota-gut-brain axis: An emerging role for the epigenome
Louwies, T., Johnson, A. C., Orock, A. M., Yuan, T., & Meerveld, B. G. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219891690 · Cited by 71
Colitis-Induced Microbial Perturbation Promotes Postinflammatory Visceral Hypersensitivity
Esquerre, N., Basso, L., Defaye, M., Vicentini, F., Cluny, N. L., Bihan, D. G., Hirota, S. A., Schick, A., Jijon, H. B., Lewis, I. A., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.003 · Cited by 77
Jalanka, J., Salonen, A., Fuentes, S., & de Vos, W. M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1096486 · Cited by 61
“Several studies have reported differences in the intestinal microbiota composition of IBS patients and healthy controls, however the results show little overlap from study to study.(7,8) This is likely caused by different methodological approaches in the analysis steps as well as the heterogeneity of the IBS patients.”
ResultSelf-citationThe microbiome and disorders of the central nervous system
Felice, V. D., & O'Mahony, S. M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.016 · Cited by 60
“Formula-fed infants tend to have a more diverse microbiota, characterised by a lower number of Bifidobacterium cells (although this still the dominant species), an increased abundance of Bacteroides and higher numbers of Atopobium.”
InfluentialReview of the role of probiotics in gastrointestinal diseases in adults
Domingo, J. J. S. (2017) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2016.12.001 · Cited by 68
Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024) · Nutrients · doi:10.3390/nu16132114 · Cited by 81
Maccaferri, S., Candela, M., Turroni, S., Centanni, M., Severgnini, M., Consolandi, C., Cavina, P., & Brigidi, P. (2012) · Gut Microbes · doi:10.4161/gmic.21009 · Cited by 57
Blastocystis and irritable bowel syndrome: Frequency and subtypes from Iranian patients
Khademvatan, S., Masjedizadeh, R., Rahim, F., Mahbodfar, H., Kahyesh, R. S., Yousefi-Razin, E., & Foroutan, M. (2017) · Parasitology International · doi:10.1016/j.parint.2017.01.005 · Cited by 66
Ringel-Kulka, T., Benson, A. K., Carroll, I. M., Kim, J., Legge, R. M., & Ringel, Y. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00044.2015 · Cited by 53
What’s bugging your teen?—The microbiota and adolescent mental health
McVey Neufeld, K.-A., Luczynski, P., Seira Oriach, C., Dinan, T. G., & Cryan, J. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.005 · Cited by 56
“IBS is a functional bowel disorder with symptoms of altered bowel habits, visceral hypersensitivity and often co-morbid anxiety and depressive symptoms.”
InfluentialKang, D.-W., DiBaise, J. K., Ilhan, Z. E., Crowell, M. D., Rideout, J. R., Caporaso, J. G., Rittmann, B. E., & Krajmalnik-Brown, R. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.01.005 · Cited by 55
The human intestinal microbiota
Dore, J. M., & Corthier, G. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70015-4 · Cited by 88
Metadata
- Authors
- Salonen, A., de Vos, W. M., & Palva, A.
- Affiliations
- University of Helsinki (FI)
- Laboratory of Microbiology, Wageningen University, Dreijenplein 10, 6703 HB Wageningen, The Netherlands
- ORCID
- Salonen, Anne
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 2010-11-01
- Volume
- 156
- Issue
- 11
- Pages
- 3205-3215
- ISSN
- 1350-0872 (ISSN-L)
- 1465-2080
- OpenAlex
- W2118173539
- Cited by
- 264
- References
- 59
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 8 · 2021: 20 · 2020: 16 · 2019: 11 · 2018: 8 · 2017: 18 · 2016: 21 · 2015: 20 · 2014: 31 · 2013: 29 · 2012: 30
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Licence
- cc-by
- Locations
- Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- Tekes
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- irritable bowel syndrome, gut microbiota, dysbiosis, functional gastrointestinal disorders, Rome criteria, microbial biomarkers, IBS diagnosis, molecular microbiology
- MeSH terms
- Bacteria, DNA, Bacterial, Feces, Humans, Phylogeny, Biomarkers, Gastrointestinal Tract, Irritable Bowel Syndrome, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.